Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ramoner

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Leukocyte Biology|December 16, 1998
Nordihydroguaiaretic acid blocks secretory and endocytic pathways in human dendritic cellsR Ramoner, C Rieser, G Bartsch, et al.
Immunology Letters|February 27, 2001
A clinically approved oral vaccine against pneumotropic bacteria induces the terminal maturation of CD83+ immunostimulatory dendritic cellsC Zelle-Rieser, R Ramoner, G Bartsch, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 9, 2001
The disabled dendritic cellM Thurnher, C Zelle-Rieser, R Ramoner, et al.
Urologia Internationalis|February 27, 1999
Dendritic cell-based immunotherapy of renal cell carcinomaM Thurnher, C Rieser, L Höltl, et al.
Lancet (London, England)|November 5, 1998
CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancerL Höltl, C Rieser, C Papesh, et al.
The Journal of Urology|April 29, 1998
Activation of human dendritic cells by bacillus Calmette-GuerinR Ramoner, C Rieser, M Herold, et al.
European Journal of Immunology|August 26, 1998
Human monocyte-derived dendritic cells produce macrophage colony-stimulating factor: enhancement of c-fms expression by interleukin-10C Rieser, R Ramoner, G Böck, et al.
The Prostate. Supplement|November 1, 2000
Effects of alpha1-adrenoceptor antagonists on cultured prostatic smooth muscle cellsS T Boesch, G Dobler, R Ramoner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotypeA Hobisch, R Ramoner, D Fuchs, et al.
Blood|May 23, 1998
Differential deactivation of human dendritic cells by endotoxin desensitization: role of tumor necrosis factor-alpha and prostaglandin E2C Rieser, C Papesh, M Herold, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Leukocyte Biology|December 16, 1998
Nordihydroguaiaretic acid blocks secretory and endocytic pathways in human dendritic cellsR Ramoner, C Rieser, G Bartsch, et al.
Immunology Letters|February 27, 2001
A clinically approved oral vaccine against pneumotropic bacteria induces the terminal maturation of CD83+ immunostimulatory dendritic cellsC Zelle-Rieser, R Ramoner, G Bartsch, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 9, 2001
The disabled dendritic cellM Thurnher, C Zelle-Rieser, R Ramoner, et al.
Urologia Internationalis|February 27, 1999
Dendritic cell-based immunotherapy of renal cell carcinomaM Thurnher, C Rieser, L Höltl, et al.
Lancet (London, England)|November 5, 1998
CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancerL Höltl, C Rieser, C Papesh, et al.
The Journal of Urology|April 29, 1998
Activation of human dendritic cells by bacillus Calmette-GuerinR Ramoner, C Rieser, M Herold, et al.
European Journal of Immunology|August 26, 1998
Human monocyte-derived dendritic cells produce macrophage colony-stimulating factor: enhancement of c-fms expression by interleukin-10C Rieser, R Ramoner, G Böck, et al.
The Prostate. Supplement|November 1, 2000
Effects of alpha1-adrenoceptor antagonists on cultured prostatic smooth muscle cellsS T Boesch, G Dobler, R Ramoner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotypeA Hobisch, R Ramoner, D Fuchs, et al.
Blood|May 23, 1998
Differential deactivation of human dendritic cells by endotoxin desensitization: role of tumor necrosis factor-alpha and prostaglandin E2C Rieser, C Papesh, M Herold, et al.
Pageof 3